Please ensure Javascript is enabled for purposes of website accessibility

3 Tips for Coronavirus Investing Right Now

By Adria Cimino - Jul 5, 2021 at 6:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Whether you're a cautious or aggressive investor, there's something for you in this space.

Coronavirus vaccine stocks have soared over the past year. But it's not too late to start investing in this dynamic space. In this Motley Fool Live video recorded on June 22, healthcare and cannabis bureau editor and analyst Olivia Zitkus and contributor Adria Cimino discuss a few points that will help you make the right decision for your portfolio.

Olivia Zitkus: I did want to get your three takeaways for healthcare investors from this talk. Then I've got other stuff we can chat about if time allows. Three takeaways for us -- whatever you think is most important from this chat.

Adria Cimino: I think that there's still opportunity for latecomers. If a company's a latecomer to the market, we shouldn't say put them all in the same bag. But you have to look at each one carefully. Their success depends on many factors. So, we have to look at each individually. Some latecomers can be very successful. Others can be, well, forget it they're too late. We have to look at each one individually. Second one would be: Don't invest in a company for the COVID vaccine only. I think that's what happened a lot with Ocugen (OCGN -3.61%) as we saw in the share movement. It was proof that they invested just for that, and that's a shame. Ocugen, it's worth taking a second look at the company. They do gene therapy for eye diseases but they're very early stage. It's good, if you want to invest in that company, to be investing in it for everything and to hold on for the long term. Also, my third point, I think, would be you should take a look at treatment makers if you want to invest also in the coronavirus space. We haven't seen huge gains that vaccine stocks have had, but they are another area that could be very interesting. We've got treatment makers like Regeneron (REGN -1.91%) that haven't gained as much, but they could gain in the long term.

Adria Cimino has no position in any of the stocks mentioned. Olivia Zitkus has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Regeneron Pharmaceuticals, Inc. Stock Quote
Regeneron Pharmaceuticals, Inc.
$636.34 (-1.91%) $-12.36
Ocugen, Inc. Stock Quote
Ocugen, Inc.
$2.67 (-3.61%) $0.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.